Норвешка - Норвешки - Statens legemiddelverk

viatris limited - tamsulosinhydroklorid - kapsel med modifisert frisetting, hard - 0.4 mg

Норвешка - Норвешки - Statens legemiddelverk

astellas pharma a/s - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg

Европска Унија - Норвешки - EMA (European Medicines Agency)

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - andre nervesystemet narkotika - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

Европска Унија - Норвешки - EMA (European Medicines Agency)

pacira ireland limited - bupivacaine - acute pain - amides, anesthetics, local - exparel liposomal is indicated:in adults as a brachial plexus block or femoral nerve block for treatment of post-operative pain. in adults and children aged 6 years or older as a field block for treatment of somatic post-operative pain from small- to medium-sized surgical wounds.

Норвешка - Норвешки - Statens legemiddelverk

hexal a/s - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Норвешка - Норвешки - Statens legemiddelverk

orion corporation - espoo - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Норвешка - Норвешки - Statens legemiddelverk

alimera sciences limited (1) - fluocinolonacetonid - intravitrealt implantat i applikator - 190 mikrog

Европска Унија - Норвешки - EMA (European Medicines Agency)

accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiske midler - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.

Норвешка - Норвешки - Statens legemiddelverk

medical valley invest ab - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg

Норвешка - Норвешки - Statens legemiddelverk

newbury pharmaceuticals ab - solifenacinsuksinat / tamsulosinhydroklorid - tablett med modifisert frisetting - 6 mg / 0.4 mg